These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 1721595)
1. [Presence of anti-alphafetoprotein immunoglobulin G in serum of a patient with hepatocellular carcinoma]. Sassi F; Ayed K; el Gaied A; Dellagi K Gastroenterol Clin Biol; 1991; 15(8-9):661-2. PubMed ID: 1721595 [No Abstract] [Full Text] [Related]
2. Presence of immunoglobulin G in human sera binding to alphafetoprotein. Nakata K; Muro T; Furukawa R; Kono K; Kusumoto Y; Ishii N; Munehisa T; Koji T; Nagataki S Oncodev Biol Med; 1983; 4(6):C101-4. PubMed ID: 6196748 [TBL] [Abstract][Full Text] [Related]
3. [Relation between serum markers of hepatitis B virus and alpha fetoprotein in hepatocellular carcinoma in France]. Attali P; Prod'homme S; Pelletier G; Papoz L; Buffet C; Etienne JP Gastroenterol Clin Biol; 1986 Oct; 10(10):637-40. PubMed ID: 2431948 [TBL] [Abstract][Full Text] [Related]
4. Cryptic epitopes on alpha-fetoprotein induce spontaneous immune responses in hepatocellular carcinoma, liver cirrhosis, and chronic hepatitis patients. Bei R; Budillon A; Reale MG; Capuano G; Pomponi D; Budillon G; Frati L; Muraro R Cancer Res; 1999 Nov; 59(21):5471-4. PubMed ID: 10554020 [TBL] [Abstract][Full Text] [Related]
5. Presence of a hepatoma-liver antigen in the sera of patients with primary hepatocellular carcinoma. Oon CJ; Yo Sui Lan Singapore Med J; 1979 Jun; 20(2):317-22. PubMed ID: 92056 [No Abstract] [Full Text] [Related]
6. [Prevalence and prognostic value of serum anti-p53 antibodies in hepatocellular carcinoma. A study of 159 patients]. Sitruk V; Vaysse J; Chevret S; Ganne-Carrie N; Christidis C; Trinchet J; Beaugrand M Gastroenterol Clin Biol; 2000 Dec; 24(12):1159-63. PubMed ID: 11173728 [TBL] [Abstract][Full Text] [Related]
7. Analysis of CD4+ T-Cell responses to a novel alpha-fetoprotein-derived epitope in hepatocellular carcinoma patients. Alisa A; Ives A; Pathan AA; Navarrete CV; Williams R; Bertoletti A; Behboudi S Clin Cancer Res; 2005 Sep; 11(18):6686-94. PubMed ID: 16166448 [TBL] [Abstract][Full Text] [Related]
8. Localization of radioiodinated antibody to alpha-fetoprotein in hepatoma transplanted in rats and a case report of alpha-fetoprotein antibody treatment of a hepatoma patient. Koji T; Ishii N; Munehisa T; Kusumoto Y; Nakamura S; Tamenishi A; Hara A; Kobayashi K; Tsukada Y; Nishi S; Hirai H Cancer Res; 1980 Aug; 40(8 Pt 2):3013-5. PubMed ID: 6156759 [No Abstract] [Full Text] [Related]
9. Proceedings: Serum alphafetoprotein levels in liver disease: relation to hepatocellular regeneration and development of hepatoma. Eleftheriou N; Thomas H; Heathcote J; Sherlock S Gut; 1975 Oct; 16(10):835. PubMed ID: 54283 [No Abstract] [Full Text] [Related]
10. Alphafetoprotein levels measured by radioimmunoassay in various liver malignancies. Chang FY; Chen TC; Fong MS; Lin S; Yeh SH Taiwan Yi Xue Hui Za Zhi; 1982 Feb; 81(2):224-31. PubMed ID: 6178794 [No Abstract] [Full Text] [Related]
11. Editorial on "a revised scoring system utilizing serum alphafetoprotein levels to expand candidates for living donor liver transplantation in hepatocellular carcinoma". Lo CM Surgery; 2007 Jul; 142(1):119-20. PubMed ID: 17630008 [No Abstract] [Full Text] [Related]
12. Serum alpha-fetoprotein and hepatocellular carcinoma size. Piantino P; Fusaro A; Daziano E J Nucl Med Allied Sci; 1989; 33(3 Suppl):131. PubMed ID: 2480412 [No Abstract] [Full Text] [Related]
13. The humoral immune response to p53 in patients with hepatocellular carcinoma is specific for malignancy and independent of the alpha-fetoprotein status. Volkmann M; Müller M; Hofmann WJ; Meyer M; Hagelstein J; Räth U; Kommerell B; Zentgraf H; Galle PR Hepatology; 1993 Sep; 18(3):559-65. PubMed ID: 7689531 [TBL] [Abstract][Full Text] [Related]
14. Serum alpha-fetoprotein and hepatitis B antigen in subjects with hepatoma in south India. Hill PG; Johnson S; Madanagopalan N Indian J Med Res; 1977 Apr; 65(4):482-7. PubMed ID: 71266 [No Abstract] [Full Text] [Related]
15. The low positive rate of serum alpha-fetoprotein levels in hepatitis C virus antibody-positive patients with hepatocellular carcinoma. Furui J; Furukawa M; Kanematsu T Hepatogastroenterology; 1995; 42(5):445-9. PubMed ID: 8751193 [TBL] [Abstract][Full Text] [Related]
16. Serial changes in serum alpha-fetoprotein prior to detection of hepatocellular carcinoma in liver cirrhosis. Kuwahara T; Sakai T; Majima Y; Hirai K; Tanikawa K Hepatogastroenterology; 1993 Aug; 40(4):347-51. PubMed ID: 7691701 [TBL] [Abstract][Full Text] [Related]
17. [Biochemical markers in the neoplasms of the liver, biliary tract and pancreas]. Higashino K; Sumikawa K Nihon Rinsho; 1982; 40(1):43-50. PubMed ID: 6177881 [No Abstract] [Full Text] [Related]
18. Marked episodic elevations of alpha-fetoprotein without hepatocellular carcinoma in a patient with hepatitis B. Wong CB; Attar BM; Shimoda SS Am J Gastroenterol; 1995 Jun; 90(6):1015-6. PubMed ID: 7539578 [No Abstract] [Full Text] [Related]
19. [Immunologic and immuno-histochemical determination of alpha l-fetoprotein and HBs antigens in hepatocellular carcinoma]. Perisić-Savić M; Perisić V; Sinćić M; Janev A; Nastić-Mirić D Srp Arh Celok Lek; 1981; 109(5-6):775-82. PubMed ID: 6179170 [No Abstract] [Full Text] [Related]
20. Hepatitis B surface antigen and alpha-1-fetoprotein in hepatoma. Reports of 157 cases. Pongpipat D; Suvatte V; Plengvanit U; Chinapak O; Bunyaphisit S; Assateerawatts A J Med Assoc Thai; 1983 Nov; 66(11):696-9. PubMed ID: 6200559 [No Abstract] [Full Text] [Related] [Next] [New Search]